41.34
price up icon3.02%   1.21
after-market Handel nachbörslich: 41.47 0.13 +0.31%
loading
Schlusskurs vom Vortag:
$40.13
Offen:
$40.31
24-Stunden-Volumen:
465.50K
Relative Volume:
1.03
Marktkapitalisierung:
$741.53M
Einnahmen:
$116.88M
Nettoeinkommen (Verlust:
$-25.09M
KGV:
-295.29
EPS:
-0.14
Netto-Cashflow:
$-20.74M
1W Leistung:
+6.41%
1M Leistung:
+70.54%
6M Leistung:
+103.75%
1J Leistung:
+208.28%
1-Tages-Spanne:
Value
$39.35
$41.35
1-Wochen-Bereich:
Value
$37.97
$41.35
52-Wochen-Spanne:
Value
$12.66
$43.72

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
Firmenname
Rigel Pharmaceuticals
Name
Telefon
650-624-1100
Name
Adresse
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
164
Name
Twitter
@rigelpharma
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
RIGL's Discussions on Twitter

Vergleichen Sie RIGL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RIGL
Rigel Pharmaceuticals
41.34 719.83M 116.88M -25.09M -20.74M -0.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-04-03 Fortgesetzt Piper Sandler Neutral
2022-06-09 Herabstufung Citigroup Buy → Neutral
2022-06-08 Herabstufung Cantor Fitzgerald Overweight → Neutral
2022-06-08 Herabstufung Piper Sandler Overweight → Neutral
2022-03-23 Eingeleitet B. Riley Securities Neutral
2020-11-09 Herabstufung JP Morgan Overweight → Neutral
2019-11-15 Fortgesetzt Cantor Fitzgerald Overweight
2019-09-26 Fortgesetzt JP Morgan Overweight
2019-03-01 Bestätigt Cantor Fitzgerald Overweight
2018-08-27 Eingeleitet Citigroup Buy
2018-05-02 Bestätigt Cantor Fitzgerald Overweight
2017-12-21 Fortgesetzt Piper Jaffray Overweight
2017-12-15 Eingeleitet Cantor Fitzgerald Overweight
2017-11-06 Fortgesetzt H.C. Wainwright Buy
2017-03-09 Bestätigt H.C. Wainwright Buy
2016-08-31 Bestätigt H.C. Wainwright Buy
2016-08-30 Bestätigt Piper Jaffray Overweight
2016-07-13 Eingeleitet H.C. Wainwright Buy
2016-06-13 Eingeleitet Piper Jaffray Overweight
2016-04-22 Hochstufung JP Morgan Neutral → Overweight
2013-04-08 Bestätigt Stifel Buy
2012-11-29 Eingeleitet UBS Neutral
2012-11-06 Bestätigt Oppenheimer Outperform
2012-03-26 Eingeleitet Canaccord Genuity Hold
2010-12-10 Herabstufung MP Advisors Outperform → Market Perform
Alle ansehen

Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten

pulisher
11:50 AM

Can Rigel Pharmaceuticals Inc. continue delivering strong returnsQuarterly Profit Review & Free Long-Term Investment Growth Plans - خودرو بانک

11:50 AM
pulisher
04:41 AM

Price momentum metrics for Rigel Pharmaceuticals Inc. explained2025 Stock Rankings & Real-Time Volume Triggers - Newser

04:41 AM
pulisher
04:34 AM

Can Rigel Pharmaceuticals Inc. lead its sector in growth2025 Investor Takeaways & Long-Term Safe Return Strategies - خودرو بانک

04:34 AM
pulisher
Sep 05, 2025

Do Options Traders Know Something About RIGL Stock We Don't? - sharewise.com

Sep 05, 2025
pulisher
Sep 05, 2025

What’s the MACD signal for Rigel Pharmaceuticals Inc.Trade Performance Summary & High Conviction Buy Zone Picks - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Using data models to predict Rigel Pharmaceuticals Inc. stock movementMarket Activity Report & Free Daily Entry Point Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What earnings revisions data tells us about Rigel Pharmaceuticals Inc.Options Play & Community Consensus Picks - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Will Rigel Pharmaceuticals Inc. bounce back from current supportJuly 2025 Decliners & Target Return Focused Picks - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Technical analysis overview for Rigel Pharmaceuticals Inc. stockJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Rigel Pharmaceuticals Inc. stock prediction for this weekPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Will a bounce in Rigel Pharmaceuticals Inc. offer an exitJuly 2025 Market Mood & AI Powered Market Entry Strategies - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Using R and stats models for Rigel Pharmaceuticals Inc. forecastingJuly 2025 Patterns & Daily Profit Maximizing Tips - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Pattern recognition hints at Rigel Pharmaceuticals Inc. upsideJuly 2025 Gainers & Free Growth Oriented Trading Recommendations - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What to expect from Rigel Pharmaceuticals Inc. in the next 30 daysWeekly Profit Report & Free Daily Entry Point Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Analyzing recovery setups for Rigel Pharmaceuticals Inc. investorsEarnings Risk Report & AI Enhanced Trading Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What are Rigel Pharmaceuticals Inc.’s recent SEC filings showingEarnings Trend Report & Weekly Stock Performance Updates - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Is Rigel Pharmaceuticals Inc.’s growth already priced inTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Historical volatility pattern of Rigel Pharmaceuticals Inc. visualizedGap Up & Weekly Setup with High ROI Potential - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Developing predictive dashboards with Rigel Pharmaceuticals Inc. dataAnalyst Upgrade & Accurate Intraday Trade Tips - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can technical indicators confirm Rigel Pharmaceuticals Inc.’s reversalWatch List & Safe Entry Point Identification - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Tools to monitor Rigel Pharmaceuticals Inc. recovery probabilityWeekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Sector ETF performance correlation with Rigel Pharmaceuticals Inc.July 2025 Institutional & Fast Entry and Exit Trade Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Automated trading signals detected on Rigel Pharmaceuticals Inc.Quarterly Growth Report & Daily Entry Point Alerts - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is Rigel Pharmaceuticals Inc. a candidate for recovery playOil Prices & Real-Time Stock Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Rigel Pharmaceuticals at Cantor Conference: Strategic Growth and Expansion - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Will Rigel Pharmaceuticals Inc. continue its uptrendSwing Trade & Expert Verified Stock Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Does Rigel Pharmaceuticals (NASDAQ:RIGL) Have A Healthy Balance Sheet? - simplywall.st

Sep 03, 2025
pulisher
Sep 03, 2025

Smart tools for monitoring Rigel Pharmaceuticals Inc.’s price actionJuly 2025 Action & Fast Entry and Exit Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Rigel Pharmaceuticals Inc. stock outlook for YEARWeekly Profit Recap & Verified Trade Idea Suggestions - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Multi asset correlation models including Rigel Pharmaceuticals Inc.Trend Reversal & Reliable Entry Point Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

What is Rigel Pharmaceuticals Inc. s debt to equity ratioWeekly Stock Recap & Community Shared Stock Ideas - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Can Rigel Pharmaceuticals Inc. navigate macro headwindsQuarterly Portfolio Report & Verified Entry Point Signals - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Backtesting results for Rigel Pharmaceuticals Inc. trading strategiesTrade Volume Report & Long-Term Safe Investment Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Rigel Pharmaceuticals Inc. Reverse From Oversold ConditionsJuly 2025 Institutional & Capital Protection Trading Alerts - beatles.ru

Sep 02, 2025
pulisher
Sep 02, 2025

Rigel Pharmaceuticals shares fall 1.13% premarket after DelveInsight's report on TGFB Inhibitor pipeline. - AInvest

Sep 02, 2025
pulisher
Sep 01, 2025

Why is Rigel Pharmaceuticals Inc. stock going downMarket Sentiment Review & Precise Trade Entry Recommendations - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Evaluating Rigel Pharmaceuticals Inc. with trendline analysisJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - Newser

Sep 01, 2025

Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Rigel Pharmaceuticals-Aktie (RIGL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Schorno Dean L
EVP & Chief Financial Officer
Feb 05 '25
Sale
21.93
1,734
38,020
57,235
Santos David A
EVP, Chief Commercial Officer
Feb 04 '25
Sale
20.92
2,125
44,457
53,500
Santos David A
EVP, Chief Commercial Officer
Feb 05 '25
Sale
21.93
1,796
39,379
51,704
RODRIGUEZ RAUL R
CEO, President
Feb 04 '25
Sale
20.92
4,952
103,601
243,854
RODRIGUEZ RAUL R
CEO, President
Feb 05 '25
Sale
21.93
4,400
96,474
239,454
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Feb 04 '25
Sale
20.92
1,448
30,294
40,169
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Feb 05 '25
Sale
21.93
1,339
29,359
38,830
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):